Novo Integrated Sciences, Inc. provided revenue guidance for the third quarter of fiscal year 2022. For the quarter, the company's revenue is expected to be in the range of $13.4 million to $13.9 million, an increase of approximately 367% to 384%, as compared to the second quarter of fiscal year 2022, and an increase of approximately 463% to 484%, as compared to the third quarter of fiscal 2021. The company's strong revenue performance in the third quarter was driven primarily by an increase in both proprietary and outsourced product sales.